NCT05627986

Brief Summary

Shoulder pain is a common musculoskeletal system complaint, accounting for 7-34% of patients in the clinic. The most common shoulder problem is subacromial impingement syndrome (SIS). Up to 45% of individuals with SIS may have unsuccessful treatment and still complain of symptoms after 2 years. This chronicity of pain may not be fully explained by structural injuries or damage, but may be related to sensorimotor changes. Decreased corticospinal excitability and increase inhibition have been found in individuals with SIS. These central motor changes may link to alteration in pain and nociception processing and the somatosensory system, which has been found in individuals with low back pain. Hyperalgesia has been found over both affected and unaffected shoulders in patients with SIS, indicating central and peripheral sensitization. However, no study has investigated whether there are changes in the central somatosensory system. Therefore, the objectives of this proposal are (1) to investigate the corticomotor and somatosensory system in patients with SIS (2) to investigate the relationship between the corticomotor and somatosensory alterations in patients with SIS. Subjects with chronic SIS and healthy subjects were recruited, with 32 people in each group. Electroencephalography (EEG) will be used to collect somatosensory activity, including somatosensory evoked potentials, spectral analysis of EEG oscillations and event-related spectral perturbation (ERSP) of the shoulder movement. Electromyography will be used to record muscle activity. Transcranial magnetic stimulation will be used to test corticomotor excitability, including active motor threshold, motor evoked potentials, cortical silent period, and intracortical inhibition and facilitation. The pressure pain threshold will be collected by a pressure algometer on the muscles of bilateral arms and legs. Pain intensity will be assessed with the Numeric Rating Scale. Shoulder function will be evaluated with the Disability of Arm, Shoulder and Hand questionnaire. Depression will be evaluated with Center for Epidemiologic Studies Depression Scale (CES-D).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 28, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 16, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 28, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 5, 2023

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

November 15, 2024

Status Verified

November 1, 2024

Enrollment Period

11 months

First QC Date

November 16, 2022

Last Update Submit

November 13, 2024

Conditions

Keywords

Shoulder Impingement SyndromeCorticospinal systemsomatosensory system

Outcome Measures

Primary Outcomes (13)

  • Corticomotor excitability measures - Active motor threshold

    Active motor threshold (AMT) will be described with the percentage (%) of maximum stimulator output (MSO).

    Immediately during the experiment

  • Corticomotor excitability measures - Motor evoked potential

    Motor evoked potential (MEP) will be described with millivolt (mV).

    Immediately during the experiment

  • Corticomotor excitability measures - Cortical silent period

    Cortical silent period (CSP) will be measured with millisecond (ms)

    Immediately during the experiment

  • Corticomotor excitability measures - Short interval cortical inhibition

    Short interval cortical inhibition (SICI) will be defined as percentage (%) of conditioning responses vs testing responses while the inter-stimulus interval is below 5 ms

    Immediately during the experiment

  • Corticomotor excitability measures - Short interval cortical facilitation

    Short interval cortical facilitation (SICF) will be defined as percentage (%) of conditioning responses vs testing responses while the inter-stimulus interval is above 5 ms

    Immediately during the experiment

  • Corticomotor excitability measures - Long-interval intracortical inhibition

    Long-interval intracortical inhibition (LICI) will be defined as percentage (%) of conditioning responses vs testing responses while the inter-stimulus interval is below 5 ms

    Immediately during the experiment

  • Corticomotor excitability - Area of cortical mapping

    Area of cortical mapping will be described with square millimeter (mm2)

    Immediately during the experiment

  • Corticomotor excitability - Volume of cortical mapping

    Volume of cortical mapping will be calculated with multiplying summation of motor evoke potentials on the map (mV) by the area of the map (mm2) with the unit of mV\*mm2

    Immediately during the experiment

  • Corticomotor excitability - Center of gravity of cortical mapping

    Center of gravity of cortical mapping will be described in a x-y coordinate system (mm).

    Immediately during the experiment

  • Resting brain activity - resting EEG with eye open/closed

    EEG signals will be processed with power spectrum density analysis to calculate frequency power at Theta (3-8 Hz), alpha (8-13 Hz), beta (13-30 Hz) bands, and Gamma (30 Hz above).

    Immediately during the experiment

  • Somatosensory cortical activity - Somatosensory evoked potentials

    Somatosensory evoked potentials (SEP) will be described with microvolt (µV) and millisecond (ms).

    Immediately during the experiment

  • Event-related synchronization or desynchronization - Movement evoked pain potentials

    Movement evoked pain potentials will be processed with power spectrum density analysis to calculate frequency power at Theta (3-8 Hz), alpha (8-13 Hz), beta (13-30 Hz) bands, and Gamma (30 Hz above) while raising hand.

    Immediately during the experiment

  • Muscle activation during arm elevation

    The root mean square of electromyography (EMG) data of the anterior deltoid and infraspinatus will be normalized by the maximum voluntary contraction amplitude (percentage of maximal voluntary contraction, %) and calculated in two segments, including arm elevating and arm lowering.

    Immediately during the experiment

Secondary Outcomes (5)

  • Shoulder pain and function-Taiwan version of the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire

    Immediately during the experiment

  • Depression- Taiwan version of the Center for Epidemiologic Studies Depression Scale (CES-D)

    Immediately during the experiment

  • Pressure pain thresholds

    Immediately during the experiment

  • Electrical sensory threshold

    Immediately during the experiment

  • Electrical pain threshold

    Immediately during the experiment

Study Arms (2)

chronic shoulder impingement syndrome

Subjects with shoulder impingement more than 6 months will be included to assess pain threshold, neurophysiological measurements of scapular muscles.

Other: No intervention

control group

Healthy controls without any shoulder and neck problems will be included to compare the differences in pain threshold, neurophysiological measurements of scapular muscles, scapular kinematics and muscle activation between healthy subjects and subjects with chronic or acute shoulder impingement syndrome.

Other: No intervention

Interventions

No intervention

chronic shoulder impingement syndromecontrol group

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with chronic impingement syndrome, acute/subacute impingement syndrome and the matched healthy control subjects.

You may qualify if:

  • individuals have shoulder pain localized at the anterior or lateral aspect of shoulder more than six months
  • are aged 20 to 65 years old
  • shoulder impingement syndrome, which is confirmed by having at least three of the following: (a) positive Neer's test, (b) positive Hawkins-Kennedy test, (c) positive empty can test, (d) positive resisted external rotation test, and (e) presenting painful arc during arm elevation
  • individuals have shoulder pain localized at the anterior or lateral aspect of shoulder less than six months
  • are aged 20 to 65 years old
  • shoulder impingement syndrome, which is confirmed by having at least three of the following: (a) positive Neer's test, (b) positive Hawkins-Kennedy test, (c) positive empty can test, (d) positive resisted external rotation test, and (e) presenting painful arc during arm elevation
  • individuals without any shoulder and neck problems
  • sex, age, and hand dominance match to impingement group

You may not qualify if:

  • have a history of dislocation, fracture, adhesive capsulities, or surgery of upper extremity
  • arm elevation angle less than 150 degrees
  • a history of direct contact injury to the neck or upper extremities within the past 12 months
  • brain injury and neurological impairment
  • inflammatory cause of the pain (e.g., rheumatoid arthritis)
  • neck pain
  • psychosis and symptom of headache or dizziness
  • allergy to plaster
  • contraindications to the use of TMS, assessed with a safety screening questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Yang Ming Chiao Tung University

Taipei, 112, Taiwan

Location

MeSH Terms

Conditions

Shoulder Impingement SyndromeChronic Pain

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesShoulder InjuriesWounds and InjuriesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Yin-Liang Lin, PhD

    National Yang Ming Chaio Tung University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 16, 2022

First Posted

November 28, 2022

Study Start

August 28, 2022

Primary Completion

August 5, 2023

Study Completion

April 30, 2024

Last Updated

November 15, 2024

Record last verified: 2024-11

Locations